Clinical Studies on Ustraa Foligen Actives: Minoxidil

Brief

Randomized double-blind study of topical 5% minoxidil formulations in Indian men.

Key Findings

• Novel 5% minoxidil formulation improved scalp hydration and reduced redness vs alcohol-based solutions.
• Better scalp tolerability can support long-term daily use of topical minoxidil.

Brief

Randomized placebo-controlled double-blind study of a new 5% minoxidil solution in men.

Key Findings

• 220 men were randomized; 210 completed the 16-week study using a new 5% minoxidil formulation or comparator.
• New 5% minoxidil solution produced a mean TAHC increase of +22.0 hairs/cm² vs. +20.5 hairs/cm² for the established comparator.

Brief

48-week randomized trial comparing 5% minoxidil, 2% minoxidil, and placebo in men.

Key Findings

• 5% minoxidil was superior to 2% and placebo; 45% more regrowth than 2% at 48 weeks.
• Strong evidence that 5% topical minoxidil improves hair regrowth in men.

Brief

Randomized controlled trial comparing 5% and 1% topical minoxidil in Japanese men.

Key Findings

• 300 men studied; 5% showed significantly higher non-vellus hair count vs 1%.
• 5% topical minoxidil works better than lower-strength minoxidil in Japanese men.

Brief

Randomized, open-label, 16-week parallel-group comparative study evaluating 5% cetosomal minoxidil solution vs. 5% conventional alcohol-based minoxidil solution in 80 Indian men with AGA (40 per group).

Key Findings

• Both groups showed statistically significant improvement in BASP grade and trichoscopy-measured hair density at 16 weeks (p < 0.05); cetosomal group demonstrated better scalp tolerability scores and superior Hairdex-29 QoL improvement compared to alcohol-based group.
• 5% minoxidil solution (both conventional and cetosomal) produces clinically meaningful, measurable hair density improvement in Indian men; the cetosomal carrier enhances patient experience without compromising efficacy — supporting its use for long-term adherence.

Brief

Systematic review and meta-analysis of randomized trials for androgenetic alopecia treatments.

Key Findings

• Meta-analysis found minoxidil effective for promoting hair growth in men and women with AGA.
• High-level evidence supports topical minoxidil as a credible non-surgical hair growth treatment.

Brief

Mechanistic PubMed study on minoxidil action in human hair follicle dermal papilla cells.

Key Findings

• Minoxidil increased dermal papilla cell proliferation and elongated human hair follicles in culture.
• Supports the biology that minoxidil helps prolong the hair growth phase.